Cirrhosis Liver
📧 Sign up to get email alerts when something new happens for Cirrhosis Liver.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-02-20Clinical Trial Update: Prolonged Release Pirfenidone Versus Placebo in Compensated Cirrhosis. [Phase 2]
Phase 2 trial comparing prolonged-release pirfenidone to placebo in compensated cirrhosis patients has completed.
-
CLINICAL_TRIALS trial_result · 2020-10-22Clinical Trial Update: Combination of Autologous MSC and HSC Infusion in Patients With Decompensated Cirrhosis [Phase 4]
A Phase 4 trial evaluating the combination of autologous mesenchymal stem cells (MSC) and hematopoietic stem cells (HSC) infusion in patient…
-
CLINICAL_TRIALS trial_result · 2018-10-04Clinical Trial Update: Rifaximin and Norfloxacin for Prevention of SBP in Adults With Decompensated Cirrhosis [Phase 3]
Phase 3 trial updating on rifaximin and norfloxacin for preventing spontaneous bacterial peritonitis in adults with decompensated cirrhosis;…
-
CLINICAL_TRIALS trial_result · 2018-01-30Clinical Trial Update: G-CSF in Decompensated Cirrhosis: an Open Label Trial [Phase 2, Phase 3]
Clinical trial update on G-CSF for decompensated liver cirrhosis across Phase 2 and Phase 3 with unknown status.
-
CLINICAL_TRIALS trial_result · 2018-01-30Clinical Trial Update: Evaluating in Cirrhotics With Refractory Vasoplegia the Effect of Methylene Blue [Phase 4]
Phase 4 trial evaluating methylene blue for refractory vasoplegia in cirrhotics with septic shock has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.